Neuronet

Closed project ¦
Platform to boost synergy & collaboration @IHIEurope's public-private #neurodegeneration research

[Neuronet @IMI2_NEURONET]

We're proud to announce the official update of our @IHIEurope funded @IMI2_NEURONET Decision Tool aimed at helping to help ensure that the outputs being developed by projects are relevant for regulatory and Health Technology Assessment #HTA settings.
https://t.co/8LNgNGoP6y

[Innovative Health Initiative @IHIEurope]

It's #BrainAwarenessWeek 🧠 and we're shining the spotlight on a recent issue of Frontiers in Neurology which focused on the impact that IMI projects have had on #AlzheimersDisease🙌📖 Read it@ https://t.co/iuw10MvGZT #BrainResearch #IHITransformingHealth #HealthResearch

[Innovative Health Initiative @IHIEurope]

This #WorldAlzheimersDay, visit our health spotlight on #dementia. Our research helps to:
🧬 unravel the genes behind #Alzheimers
👩‍🔬 reduce failure rates of dementia #ClinicalTrials
💻Leverage #BigData & #AI to deliver personalised treatment
➡️https://t.co/wgN7uuPW7B

[Alzheimer's Disease Data Initiative @AlzData]

Get the latest in #ADRD research from our partners @IMI_AMYPAD, whose groundbreaking Prognostic Study data is permissibly available on #ADWorkbench, our secure, global, and free data sharing and analysis platform: https://t.co/39olVbCpBF

[Innovative Health Initiative @IHIEurope]

Have you read our July #newsletter yet?

✅ Apply now for calls 4 & 5!
✅120 people joined our Patient Pool
✅IMI has >10K publications 📚
✅2 new IHI projects: IDERHA & @IHI_PROMINENT
✅New #AMR treatment @COMBACTE
& #biomarker app @etransafe

https://t.co/1wTtU3vlfr

[IHI Prominent @IHI_PROMINENT]

Proud to partner with @SynapseManagers to improve #precisionmedicine in #neurodegeneration.
Their previous leadership in @IHIEurope funded @IMI2_NEURONET & involvement in @IMI_EHDEN presents a great opportunity for next-level collaboration.
Stay tuned: https://t.co/NgiwxXvVDq

[SYNAPSE R&D Managers @SynapseManagers]

A new @IMI2_NEURONET publication, written with Carlos Díaz and Lewis Killin, reviews the wide-ranging challenges and barriers researchers often face when sharing data, informed by experiences within @IHIEurope projects

👉https://t.co/fS9dru9GeX

[AMYPAD @IMI_AMYPAD]

📢New @IMI2_NEURONET paper out in @FrontNeurol outlining the challenges & learnings of #DataSharing in neurodegenerative disease research. Pleased that the @IMI_AMYPAD Prognostic Study is used as a case example!

@IHIEurope @AngeBradshaw_AE @DavidVallez👏

https://t.co/FWYlZEwEDR

[IDEA-FAST-Project @ideafastproject]

Dr. Chloe Hinchliffe has been awarded a stipend to attend the ISPGR 2023 Conference in Brisbane, Australia. She will hold a talk on gait variability and its association with sleep and fatigue in immune & neurodegenerative disorders.

@NIHRNewcBRC @IMI2_NEURONET @chl_hinchliffe

[IDEA-FAST-Project @ideafastproject]

New paper on Digital Endpoints of Alzheimer’s and other neurodegenerative diseases has been published, where IDEA-FAST’s effort to identify digital markers of fatigue and sleep disturbances is discussed.

Full paper here: https://t.co/5Fon3PooeW

@IMI2_NEURONET @Mobilise_D

[European Platform for Neurodegenerative Diseases @imi_epnd]

Fantastic to see the first @IHIEurope projects being launched, including #neurodegeneration initiative @IHI_PROMINENT - wishing all consortia huge success in their respective collaborations! 🧠 🫁 🧬 🧪

[IHI Prominent @IHI_PROMINENT]

🌐@IHI_Prominent is a pan-European public-private partnership funded through @IHIEurope, creating a digital platform for precision medicine in #neurodegeneration
Find out more: https://t.co/SccEugShVx

[IHI Prominent @IHI_PROMINENT]

Exciting news for #neurodegenerative🧠disease research!

Today, @IHI_PROMINENT project partners announced the launch of a collaborative pan-European 🇪🇺 initiative funded through @IHIEurope

#precisionmedicine #neurodegenerativedisease #CarryTheTorch

⤵️
https://t.co/fsNgKcX9iD

[IDEA-FAST-Project @ideafastproject]

The IDEA-FAST Webinar is fast approaching! This is a reminder to register for our webinar if you haven't so far! @IMI2_NEURONET @NIHRNewcBRC @NeurogeriatricK @Faing07

[IDEA-FAST-Project @ideafastproject]

The IDEA-FAST Midterm Achievements Report is here! This public report provides insight into our past and ongoing studies, patient engagement, project partnerships, and many other interesting topics. @IMI2_NEURONET @NIHRNewcBRC @NeurogeriatricK

Read here: https://t.co/tTgFqCsC2P

[Chris Bintener @ChrisBintener]

The latest @IHIEurope funded @IMI_AMYPAD paper shows that early amyloid PET allowed memory clinic patients to receive an etiological diagnosis with very high confidence after only 3 months compared with patients who had not undergone amyloid PET.
https://t.co/Xl2F9VcBxT

[Chris Bintener @ChrisBintener]

(1/2)
The latest @IHIEurope funded @IMI_EPAD paper proposes that dynamic eigenvector centrality is an early biomarker of the interplay between early #Alzheimer’s disease pathology & cognitive decline.
Congrats @LuigiLorenzini1 et al.!
https://t.co/J5L6RM6yD8

[Mobilise-D @Mobilise_D]

Check out this webinar where we explain the tools we use for data transfer and analysis💻🔁

🔗https://t.co/beE0hoxezC

#wearables #datatransfer #dataanalysis #digitalhealth @MobilNor @IHIEurope @EFPIA @IMI2_NEURONET

[NICE @NICEComms]

Over a million people live with a neurodegenerative disease in the UK, and despite high levels of research expenditure there are a lack of effective new treatments.

Claire Hawksworth talks about our work to speed up delivery of innovative treatments⬇️
https://t.co/2ttndUYeKI

[AMYPAD @IMI_AMYPAD]

We had a fantastic time at #ADPD2023 sharing our @IMI_AMYPAD work and listening to the latest breakthroughs in the #Alzheimer’s disease field. Thanks @adpdnet for the great event and the opportunity to present!

@IHIEurope @IMI2_NEURONET

https://t.co/li9srOO7Fy